Still, the pharma industry scored lower in 2022 for key activities that are meaningful to these rare disease patient groups, including fair pricing policies and access to medicines.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,